thyroid cancer

You have access
Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy
Ghadah Al-Naqeeb, Eric Munger, Amrita L. Ramanathan, Andrew Makarewicz, Noha Behairy, Padmasree Veraraghavan, Craig Cochran, Philip Bernaldez, Iman Clinton, Newbegin Devaraj, Korressa Lee, Teresa Fisher, Olumide Owoade, Roberto Maass-Moreno, Babak Saboury, Sriram Gubbi and Joanna Klubo-Gwiezdzinska

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1336-1339; DOI: https://doi.org/10.2967/jnumed.123.266955
You have access
The Accomplishments and Legacy of Saul Hertz, MD
Bennett S. Greenspan, Michael S. Hofman and John Buscombe

Journal of Nuclear Medicine April 1, 2024, 65 (4) 659-663; DOI: https://doi.org/10.2967/jnumed.124.267524
You have access
Management of Patients with Renal Failure Undergoing Dialysis During ¹³¹I Therapy for Thyroid Cancer
Maximilien Vermandel, Pauline Debruyne, Amandine Beron, Laura Devos, Antoine Talbot, Jean-François Legrand, François Provôt and Georges Lion

Journal of Nuclear Medicine August 1, 2020, 61 (8) 1161-1170; DOI: https://doi.org/10.2967/jnumed.119.232017
You have access
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li and Mingzhao Xing

Journal of Nuclear Medicine February 1, 2020, 61 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.119.227652
Open Access
Enhancement of ²¹¹At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer
Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuwei Liu, Yoshifumi Shirakami, Kazuhiro Ooe, Atsushi Toyoshima, Eku Shimosegawa, Mitsuhiro Fukuda, Atsushi Shinohara and Jun Hatazawa

Journal of Nuclear Medicine September 1, 2019, 60 (9) 1301-1307; DOI: https://doi.org/10.2967/jnumed.118.222638
You have access
Controversial Issues in Thyroid Cancer Management
R. Michael Tuttle

Journal of Nuclear Medicine August 1, 2018, 59 (8) 1187-1194; DOI: https://doi.org/10.2967/jnumed.117.192559
You have access
Alternative Means of Estimating ¹³¹I Maximum Permissible Activity to Treat Thyroid Cancer
Kenneth J. Nichols, William Robeson, Miyuki Yoshida-Hay, Pat B. Zanzonico, Fritzgerald Leveque, Kuldeep K. Bhargava, Gene G. Tronco and Christopher J. Palestro

Journal of Nuclear Medicine October 1, 2017, 58 (10) 1588-1595; DOI: https://doi.org/10.2967/jnumed.117.192278
You have access
Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry–Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
Désirée Deandreis, Carole Rubino, Hernan Tala, Sophie Leboulleux, Marie Terroir, Eric Baudin, Steve Larson, James A. Fagin, Martin Schlumberger and R. Michael Tuttle

Journal of Nuclear Medicine May 1, 2017, 58 (5) 717-722; DOI: https://doi.org/10.2967/jnumed.116.179606
You have access
High Level of Agreement Between Pretherapeutic ¹²⁴I PET and Intratherapeutic ¹³¹I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases
Marcus Ruhlmann, Walter Jentzen, Verena Ruhlmann, Cinzia Pettinato, Gloria Rossi, Ina Binse, Andreas Bockisch and Sandra Rosenbaum-Krumme

Journal of Nuclear Medicine September 1, 2016, 57 (9) 1339-1342; DOI: https://doi.org/10.2967/jnumed.115.169649
You have access
Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving ¹³¹I Treatment: A Nationwide Population-Based Cohort Study
Chun-Yi Lin, Cheng-Li Lin, Wen-Sheng Huang and Chia-Hung Kao

Journal of Nuclear Medicine May 1, 2016, 57 (5) 685-690; DOI: https://doi.org/10.2967/jnumed.115.164830

Main menu

User menu

Search

thyroid cancer

Pages